Profound Medical Corp. — Form D/A
Profound Medical Corp. of MISSISSAUGA, A6, a company, filed a Form D amendment with the SEC on 2017-10-05. The offering totals $877K, of which $877K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-10-05
- Form: D/A
- Accession: 0001628808-17-000004
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $877K
- Amount sold: $877K
- Investors: 16
- Date of first sale: 2017-09-20
- Revenue range: No Revenues
- SEC file number: 021-296067
Issuer
- Name: Profound Medical Corp.
- CIK: 0001628808
- Entity type: Corporation
- Jurisdiction: ONTARIO, CANADA
- Incorporated: 2014
- Address: 2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, A6, L4W 5K5
- Phone: 647-476-1350
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| William Curran | Director | Mississauga, A6 |
| Kenneth Galbraith | Director | Vancouver, A1 |
| Damian Lamb | Director | Mississauga, A6 |
| Arun Menawat | Director | Kenmore, NY |
| Jean-Francois Pariseau | Director | Mississauga, A6 |
| Samira Sakhia | Director | Mississauga, A6 |
| Rashed Dewan | Executive Officer | Mississauga, A6 |
| Arun Menawat | Executive Officer | Kenmore, NY |
Other filings by this issuer (1)
More